Nature Medicine 2017-12-11

The deubiquitinating enzyme TNFAIP3 mediates inactivation of hepatic ASK1 and ameliorates nonalcoholic steatohepatitis

Peng Zhang, Pi-Xiao Wang, Ling-Ping Zhao, Xin Zhang, Yan-Xiao Ji, Xiao-Jing Zhang, Chun Fang, Yue-Xin Lu, Xia Yang, Mao-Mao Gao, Yan Zhang, Song Tian, Xue-Yong Zhu, Jun Gong, Xin-Liang Ma, Feng Li, Zhihua Wang, Zan Huang, Zhi-Gang She, Hongliang Li

Index: 10.1038/nm.4453

Full Text: HTML

Abstract

The deubiquitinating enzyme TNFAIP3 mediates inactivation of hepatic ASK1 and ameliorates nonalcoholic steatohepatitis The deubiquitinating enzyme TNFAIP3 mediates inactivation of hepatic ASK1 and ameliorates nonalcoholic steatohepatitis, Published online: 11 December 2017; doi:10.1038/nm.4453The deubiquitinase TNFAIP3 suppresses the kinase ASK1 to ameliorate nonalcoholic fatty liver disease.

Latest Articles:

Corrigendum: Suppression of luteinizing hormone enhances HSC recovery after hematopoietic injury

2018-04-10

[10.1038/nm0418-525b]

Current understanding of the human microbiome

2018-04-10

[10.1038/nm.4517]

Transplanted neural progenitors bridge gaps to benefit cord–injured monkeys

2018-04-10

[10.1038/nm.4531]

Predicting leukemia relapse

2018-04-10

[10.1038/nm.4529]

A new site of attack for a malaria vaccine

2018-04-10

[10.1038/nm.4533]

More Articles...